KCNJ2 and Mobius syndrome: Our findings demonstrate that Kir2.1 is preferentially expressed in non-WNT/SHH MBs and by recruiting Adam10 to enhance the S2 cleavage of Notch2, thereby activating the Notch2 signaling pathway in the MB subgroup.